Skip to main content

Analyst Moves: ABT, ACN, EFX, JCP

Goldman Sachs (GS) upgraded shares of Abbott Labratories (ABT) from neutral to buy citing growth of margin expansion. Additionally Goldman upgraded Accenture (ACN) shares to buy placing a $90 target price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.